In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this ...

TG Therapeutics (TGTX) announced that it has completed its previously authorized $100M share repurchase program, which was initially announced in August 2024. Under that program, the Company ...

I was saying since last year that Ocrevus is not the threat that TG bears are portraying it to be, and Roche's approval press release confirms that the convenience of Ocrevus Zunovo is not really that ...